Average Co-Inventor Count = 2.60
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Beijing Innocare Pharma Tech Co., Ltd. (13 from 14 patents)
2. Guangzhou Innocare Pharma Tech Co., Ltd. (6 from 6 patents)
19 patents:
1. 12448382 - Heterocyclic compounds for mediating tyrosine kinase 2 activity
2. 12391666 - Indoline-1-formamide compound, preparation method therefor, and medical use thereof
3. 12297188 - Crystalline forms of (S)-1-(1-acryloylpyrrolidin-3-yl)-3-((3,5-dimethoxyphenyl)ethynyl)-5-(methylamino)-1H-pyrazole-4-carboxamide
4. 12202813 - Process for preparing 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide
5. 12178808 - Amorphous solid dispersion comprising 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide
6. 12162873 - Substituted nicotinimide inhibitors of BTK for treating cancer
7. 11945792 - Crystalline forms of 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide
8. 11840513 - Substituted nicotinimide inhibitors of BTK for treating cancer
9. 11578058 - Heterocyclic compounds for inhibiting TYK2 activities
10. 11572353 - Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereof
11. 11389445 - Pentafluorosulfanyl-substituted amide derivatives, preparation methods thereof and medical uses thereof
12. 11345695 - Substituted nicotinimide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
13. 11059805 - Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereof
14. 11046682 - Fused heterocyclic derivatives, their preparation methods thereof and medical uses thereof
15. 10752631 - Heterocyclic compounds as FGFR inhibitors